Mass. Gen. Laws ch. 111, sec. 2D — MA Code / Part I / Title XVI / Chapter 111 / Section 2D
Massachusetts State Health HIV and Hepatitis fund; definitions
Status: in_force

Section 2D. As used in sections 2D to 2F, inclusive, the following words shall, have the following meanings, unless the context clearly indicates otherwise:— ''AIDS'', acquired immune deficiency syndrome associated with HIV. ''AIDS advisory board'', the board established pursuant to section 2F. ''Education'', efforts to inform the public or groups within the public who are seropositive or at high risk of HIV or viral hepatitis infection with targeted information directed specifically at decreasing the incidence of unsafe behavior associated with the transfer of the HIV virus and viral hepatitis. ''Experimental treatment'', treatment for viral hepatitis, HIV infection or its associated illnesses which has not yet been approved for general use by an appropriate agency of the federal government. ''Fund'', the Massachusetts State Public Health HIV and Hepatitis Fund established pursuant to section 35R of chapter 10. ''HIV'', the human immunodeficiency virus associated with AIDS. ''Research'', scientific study conducted through community-based efforts to determine the effectiveness of drug and non-drug therapies in combatting viral hepatitis, HIV infection and its associated illness, including research into the effectiveness of educational methods and materials. ''Seropositive'', the status of having tested positive for HIV or viral hepatitis antibodies. ''Treatment'', such treatment as is approved by appropriate agencies of the United States government for viral hepatitis, HIV infection or its associated illnesses.

Section 2D. As used in sections 2D to 2F, inclusive, the following words shall, have the following meanings, unless the context clearly indicates otherwise:—

''AIDS'', acquired immune deficiency syndrome associated with HIV.

''AIDS advisory board'', the board established pursuant to section 2F.

''Education'', efforts to inform the public or groups within the public who are seropositive or at high risk of HIV or viral hepatitis infection with targeted information directed specifically at decreasing the incidence of unsafe behavior associated with the transfer of the HIV virus and viral hepatitis.

''Experimental treatment'', treatment for viral hepatitis, HIV infection or its associated illnesses which has not yet been approved for general use by an appropriate agency of the federal government.

''Fund'', the Massachusetts State Public Health HIV and Hepatitis Fund established pursuant to section 35R of chapter 10.

''HIV'', the human immunodeficiency virus associated with AIDS.

''Research'', scientific study conducted through community-based efforts to determine the effectiveness of drug and non-drug therapies in combatting viral hepatitis, HIV infection and its associated illness, including research into the effectiveness of educational methods and materials.

''Seropositive'', the status of having tested positive for HIV or viral hepatitis antibodies.

''Treatment'', such treatment as is approved by appropriate agencies of the United States government for viral hepatitis, HIV infection or its associated illnesses.